XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Capital Contributed in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Income
Total
Balance Beginning at Apr. 30, 2024 $ 526 $ 32,986 $ 83,308 $ 1,230 $ 118,050
Balance Beginning (in shares) at Apr. 30, 2024 5,271        
Issuance of restricted common stock (in shares) 16        
Stock compensation expense $ 2        
Stock compensation expense   204     206
Compensation related to issuance of option to purchase common stock   37     37
Issuance of deferred common stock units   90     90
Net income     8,823   8,823
Other comprehensive loss (income)       $ (1,230) (1,230)
Balance Ending at Jan. 31, 2025 $ 528 33,317 92,131   125,976
Balance Ending (in shares) at Jan. 31, 2025 5,287        
Balance Beginning at Oct. 31, 2024 $ 527 33,135 91,414   125,076
Balance Beginning (in shares) at Oct. 31, 2024 5,287        
Stock compensation expense $ 1        
Stock compensation expense   80     81
Compensation related to issuance of option to purchase common stock   12     12
Issuance of deferred common stock units   90     90
Net income     717   717
Balance Ending at Jan. 31, 2025 $ 528 33,317 92,131   125,976
Balance Ending (in shares) at Jan. 31, 2025 5,287        
Balance Beginning at Apr. 30, 2025 $ 528 33,409 96,024   129,961
Balance Beginning (in shares) at Apr. 30, 2025 5,287        
Issuance of restricted common stock $ 3       3
Issuance of restricted common stock (in shares) 19        
Stock compensation expense   250     250
Compensation related to issuance of option to purchase common stock   37     37
Issuance of deferred common stock units   90     90
Net income     9,039   9,039
Balance Ending at Jan. 31, 2026 $ 531 33,786 105,063   139,380
Balance Ending (in shares) at Jan. 31, 2026 5,306        
Balance Beginning at Oct. 31, 2025 $ 531 33,581 101,916   136,028
Balance Beginning (in shares) at Oct. 31, 2025 5,306        
Stock compensation expense   103     103
Compensation related to issuance of option to purchase common stock   12     12
Issuance of deferred common stock units   90     90
Net income     3,147   3,147
Balance Ending at Jan. 31, 2026 $ 531 $ 33,786 $ 105,063   $ 139,380
Balance Ending (in shares) at Jan. 31, 2026 5,306